Search research articles
Contact Us
Filters
Showing results (31-40 of 328) with videos related to
Page
of 33
Sort By:
Cold Spring Harbor Perspectives in Biology
|
July 19, 2017
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination
Stephen S Whitehead, Kanta Subbarao
The Journal of Infectious Diseases
|
January 24, 2018
Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle
Allen C Cheng, Kanta Subbarao
Plos Medicine
|
February 15, 2007
Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?
Laura Gillim-Ross, Kanta Subbarao
Nature Biotechnology
|
March 10, 2010
Cellular targets for influenza drugs
Ji-Young Min, Kanta Subbarao
Virology
|
March 21, 2015
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
Troy C Sutton, Kanta Subbarao
Current Opinion in Virology
|
November 30, 2011
Influenza virus vaccines: lessons from the 2009 H1N1 pandemic
Andrew J Broadbent, Kanta Subbarao
Nature Medicine
|
November 7, 2009
Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine
Grace L Chen, Kanta Subbarao
Current Opinion in Virology
|
July 18, 2015
Animal models for SARS and MERS coronaviruses
Lisa M Gretebeck, Kanta Subbarao
Clinical Microbiology Reviews
|
October 17, 2006
Emerging respiratory viruses: challenges and vaccine strategies
Laura Gillim-Ross, Kanta Subbarao
Nature Medicine
|
October 9, 2012
The ongoing battle against influenza: The challenge of flu transmission
Seema S Lakdawala, Kanta Subbarao
Page
of 33
Search research articles
Search
Showing results (31-40 of 328) with videos related to
Sort By:
Page
of 33
Cold Spring Harbor Perspectives in Biology
|
July 19, 2017
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination
Stephen S Whitehead, Kanta Subbarao
The Journal of Infectious Diseases
|
January 24, 2018
Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle
Allen C Cheng, Kanta Subbarao
Plos Medicine
|
February 15, 2007
Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?
Laura Gillim-Ross, Kanta Subbarao
Nature Biotechnology
|
March 10, 2010
Cellular targets for influenza drugs
Ji-Young Min, Kanta Subbarao
Virology
|
March 21, 2015
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
Troy C Sutton, Kanta Subbarao
Current Opinion in Virology
|
November 30, 2011
Influenza virus vaccines: lessons from the 2009 H1N1 pandemic
Andrew J Broadbent, Kanta Subbarao
Nature Medicine
|
November 7, 2009
Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine
Grace L Chen, Kanta Subbarao
Current Opinion in Virology
|
July 18, 2015
Animal models for SARS and MERS coronaviruses
Lisa M Gretebeck, Kanta Subbarao
Clinical Microbiology Reviews
|
October 17, 2006
Emerging respiratory viruses: challenges and vaccine strategies
Laura Gillim-Ross, Kanta Subbarao
Nature Medicine
|
October 9, 2012
The ongoing battle against influenza: The challenge of flu transmission
Seema S Lakdawala, Kanta Subbarao
Page
of 33